» Authors » Bernard Schneider

Bernard Schneider

Explore the profile of Bernard Schneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 18
Citations 635
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Velasquez E, Savchenko E, Marmolejo-Martinez-Artesero S, Challuau D, Aebi A, Pomeshchik Y, et al.
Neurobiol Dis . 2024 Oct; 201:106687. PMID: 39362568
Astrocytes play a crucial role in the onset and progression of amyotrophic lateral sclerosis (ALS), a fatal disorder marked by the degeneration of motor neurons (MNs) in the central nervous...
2.
Skinnider M, Gautier M, Teo A, Kathe C, Hutson T, Laskaratos A, et al.
Nature . 2024 Jun; 631(8019):150-163. PMID: 38898272
Here, we introduce the Tabulae Paralytica-a compilation of four atlases of spinal cord injury (SCI) comprising a single-nucleus transcriptome atlas of half a million cells, a multiome atlas pairing transcriptomic...
3.
Brown S, Soltic D, Synowsky S, Shirran S, Chilcott E, Shorrock H, et al.
Hum Mol Genet . 2023 Jul; 32(20):2950-2965. PMID: 37498175
Structural, functional and molecular cardiac defects have been reported in spinal muscular atrophy (SMA) patients and mouse models. Previous quantitative proteomics analyses demonstrated widespread molecular defects in the severe Taiwanese...
4.
Ghosal S, Gebara E, Ramos-Fernandez E, Chioino A, Grosse J, Guillot de Suduiraut I, et al.
Cell Rep . 2023 Jul; 42(7):112776. PMID: 37440411
The nucleus accumbens (NAc) is a brain hub regulating motivated behaviors, including social competitiveness. Mitochondrial function in the NAc links anxiety with social competitiveness, and the mitochondrial fusion protein mitofusin...
5.
Bazylianska V, Sharma A, Chauhan H, Schneider B, Moszczynska A
Int J Mol Sci . 2022 Jan; 23(1). PMID: 35008791
Methamphetamine (METH) is a highly abused psychostimulant that is neurotoxic to dopaminergic (DAergic) nerve terminals in the striatum and increases the risk of developing Parkinson's disease (PD). In vivo, METH-mediated...
6.
Sanchez-Mut J, Heyn H, Silva B, Dixsaut L, Garcia-Esparcia P, Vidal E, et al.
Nat Med . 2018 May; 24(5):598-603. PMID: 29736028
The chances to develop Alzheimer's disease (AD) result from a combination of genetic and non-genetic risk factors , the latter likely being mediated by epigenetic mechanisms . In the past,...
7.
Bethge P, Carta S, Lorenzo D, Egolf L, Goniotaki D, Madisen L, et al.
PLoS One . 2017 Jun; 12(6):e0179460. PMID: 28640817
Genetically encoded calcium indicators (GECIs) enable imaging of in vivo brain cell activity with high sensitivity and specificity. In contrast to viral infection or in utero electroporation, indicator expression in...
8.
Andrews M, Soleman S, Cheah M, Tumbarello D, Mason M, Moloney E, et al.
eNeuro . 2016 Aug; 3(4). PMID: 27570822
The regenerative ability of CNS axons decreases with age, however, this ability remains largely intact in PNS axons throughout adulthood. These differences are likely to correspond with age-related silencing of...
9.
Astolfo A, Lathuiliere A, Laversenne V, Schneider B, Stampanoni M
J Synchrotron Radiat . 2016 May; 23(Pt 3):813-9. PMID: 27140162
Amyloid beta accumulation into insoluble plaques (Aβp) is known to play a significant role in the pathological process in Alzheimer's disease (AD). The presence of Aβp is also one of...
10.
Liu B, Traini R, Killinger B, Schneider B, Moszczynska A
Exp Neurol . 2013 Jan; 247:359-72. PMID: 23313192
Methamphetamine (METH) is a central nervous system psychostimulant with a high potential for abuse. At high doses, METH causes a selective degeneration of dopaminergic terminals in the striatum, sparing other...